NCT03568604View on ClinicalTrials.gov

Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 7, 2018

Primary Completion Date

January 28, 2020

Study Completion Date

January 28, 2020

Conditions
Dyspareunia
Interventions
DRUG

Prasterone

6.5 vaginal insert prasterone (dehydroepiandrosterone)

Trial Locations (1)

92120

San Diego Sexual Medicine, San Diego

All Listed Sponsors
lead

San Diego Sexual Medicine

OTHER

NCT03568604 - Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia | Biotech Hunter | Biotech Hunter